Drug recall · August 6, 2014
Losartan Potassium and Hydrochlorothiazide Tablets recall
Why: Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC # 59746-339-90
- Lots / codes
Lot #14P0292, Exp 04/2016
- Quantity
- 9,358 bottles
- Company
- Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD
- Distribution
- Nationwide and Puerto Rico
- Initiated
- July 11, 2014 · Voluntary: Firm initiated
- Classified
- July 31, 2014
- Reported
- August 6, 2014
- Ended
- September 15, 2016
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide / losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.